Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

J&J Acquisitions Governed By Payback Potential, Despite Credit “Uncertainty”

  • News

Executive Summary

Maintaining a stellar credit rating is not a constraint on how much Johnson & Johnson is willing to spend on acquisitions, Chief Financial Officer Dominic Caruso said during the company's April 15 first quarter earnings call

You may also be interested in...



AstraZeneca Sales Force Restructuring Boosts Operating Profit, Not Sales

AstraZeneca's efforts to restructure its EU sales force have helped the company improve its margins

AstraZeneca Sales Force Restructuring Boosts Operating Profit, Not Sales

AstraZeneca's efforts to restructure its EU sales force have helped the company improve its margins

Bristol Readies Abilify Sales Force For Major Depressive Disorder Push

Bristol-Myers Squibb has restructured its sales force to support the launch of its atypical antipsychotic Abilify as an adjunct treatment for adults with major depressive disorder, Worldwide Pharmaceuticals Chief Operating Officer Lamberto Andreotti said during the company's 2007 fourth-quarter earnings call Jan. 31

Table

View full table

Tags:
Latest Headlines

Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings

China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’

Change Is Constant For Pneumococcal Vaccines: US CDC Prepares For Merck’s V116

Woodcock Takes On Rare Disease Challenges In Retirement, Keeps FDA, Industry At Arm’s Length

See All
UsernamePublicRestriction

Register

PS049531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By